AMP2027 Logo

AMP EUROPE
JUNE 21–23, 2027
Amsterdam

REGISTER NOW

VIEW PROGRAM

EXPLORE SPONSORSHIP OPPORTUNITIES

IMPORTANT DATES

Opening abstract submission:

December 2, 2026

Deadline abstract submission:

Februar 9, 2027

Opening registration:

January 13, 2027

Early bird deadline:

March 17, 2027

REASONS TO ATTEND AMP EUROPE

Networking

Access early results

Stay up-to-date

ABOUT THE VENUE

Amsterdam Congress Center

Address:

La Guardiaweg 59,

Amsterdam, 1043 DE,

The Netherlands

Book your room

GET ACCESS TO OUR LATEST NEWS

Stay connected with all of the latest updates by signing up to the mailing list.

By clicking on ‘Subscribe’, you agree to receive the newsletter with information on AMP Europe and to analyze it through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. You can revoke your consent at any time for the future as follows. You will find detailed information in our see our privacy statement.

ORGANIZING COMMITTEE

WELCOME ADDRESS FROM THE ORGANIZING COMMITTEE CHAIR

tba

tba

tba

tba

tba 

tba

tba

tba

Chair Jonathan Nowak MD, PhD
Boston, Massachusetts, USA
Brigham and Women's Hospital

amp-laura-tafe

Chair

Laura J. Tafe, MD
Lebanon, New Hampshire, USA
Dartmouth Hitchcock Medical Center

Mafouz_Rami

Vice-Chair

Rami Mafouz, MD, MPH
Beirut, Lebanon
American University of Beirut Medical Center

amp-reddi-h

Committee - Genetics

Honey Reddi, PhD
Sussex, Wisconsin, USA
Belay Diagnostics

amp-Iorgulescu-j

Committee - HemePath

J. Bryan Iorgulescu, MD
Houston, Texas, USA
University of Texas MD Anderson Cancer Center

amp-bard-j

Committee - Infectious Diseases

Jennifer Bard, PhD
Los Angeles, California, USA
Children Hospital Los Angeles

c-bell

Committee - Informatics

Robert C. Bell, MD
Ann Arbor, Michigan, USA
University of Michigan

amp-yemelyanova-a

Committee - Solid Tumors

Anna Yemelyanova , MD
New York, New York, USA
Weill Cornell Medical College

amp-fernanda-sabato

Committee - Tech Topics

M. Fernanda Sabato
Richmond, Virginia, USA
VCU Health

GET TO KNOW THE ASSOCIATION FOR MOLECULAR PATHOLOGY

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics.

AMP’s 3,000+ members include individuals from academic and community medical centers, government, and industry:

 including pathologist and doctoral scientist laboratory directors, basic and translational scientists, technologists, and trainees.

MORE ABOUT AMP

Laura J. Tafe

Laura Tafe is a Professor of Pathology and Laboratory Medicine at Dartmouth Hitchcock Medical Center in Lebanon, NH where she is the Director of the Laboratory for Clinical Genomics and Advanced Technology (CGAT). She works as a molecular and anatomic pathologist with expertise in pulmonary and GYN pathology and directs the Dartmouth Cancer Center’s Molecular Tumor Board. Dr. Tafe has most recently served as the AMP Past-President and as a member of the Professional Relations Committee.

Rami Mafouz, MD, MPH

Rami Mahfouz is currently a Tenured Professor and Head of Division of Clinical Pathology in the Department of Pathology and Laboratory Medicine at the American University of Beirut Medical Center and the Director of the Histocompatibility and Molecular Diagnostics Laboratory, Director of the Residency Training Program, and Chairman of the Biomedical Institutional Review Board. He is a member of several international and professional societies including the College of American Pathologists (CAP), the American Society of Histocompatibility and Immunogenetics (ASHI) and the American Association of Molecular Pathologists (AMP) where he is serving as the Chair of the International Affairs Committee.

Honey Reddi

Dr. Reddi currently serves as Chief Laboratory Officer for Belay Diagnostics. Prior to her current position, Dr. Reddi was a Professor and Chief of the Division of Clinical Genomics at the Medical College of Wisconsin. With a background in biotechnology and specialized training in Clinical Molecular Genetics from the Mayo Clinic, where she also led a translational research program on thyroid cancer, Dr. Reddi had been recognized for her outstanding contributions to the field. She received the 2023 Outstanding Graduate Educator award for her contributions as faculty and course director to the MS in Precision Medicine at MCW and the 2018 “Women of Innovation Award” for her leadership in bioscience and technology from the Connecticut Technology Council. Dr. Reddi is passionate about mentoring the next generation of laboratory geneticists.

Julian Bryan Iorgulescu

Dr. Bryan is an assistant professor and director of genomic clinical decision support in the Molecular Diagnostics Laboratory at MD Anderson Cancer Center.

Jennifer Bard

Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM is a Professor of Pathology with Clinical Scholar designation in the Department of Pathology, Keck School of Medicine, University of Southern California. She is the Chief of Clinical Operations and Director of the Clinical Microbiology and Virology Laboratories in the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles.

Robert C. Bell

Dr. Robert Bell, MD is a Clinical Assistant Professor of Pathology and Section Head of Informatics for the Division of Genetics & Genomics. With expertise in hematopathology, molecular genetic pathology, bioinformatics, and clinical informatics, he leads efforts to integrate data science and computational tools into diagnostic medicine. Dr. Bell’s work focuses on advancing genomic data interpretation, informatics infrastructure, and precision diagnostics to improve patient care and translational research.

Anna Yemelyanova

Molecular and Surgical pathologist at Weill Cornell Medical College, New York, New York

M. Fernanda Sabato

I am leading the molecular diagnostics field, specializing in genetics and genomics, oncology, precision medicine, and infectious diseases, particularly in hepatitis and transplantation using state of art technologies such as NGS. In this capacity, I collaborate on the development, validation and implementation of innovative molecular diagnostic tests, ensuring their seamless integration into clinical care. By creating, enhancing, and managing quality control (QC) and quality assurance (QA) programs, alongside driving process improvements and strategies to optimize operational efficiency, I manage and lead a molecular high-complexity CLIA/CAP laboratory in an academic medical center.
Soon!